gastroenteritis - Dientamoebiasis (Dientamoeba fragilis)
Advices
Priority | Medication | Remarks |
---|---|---|
Priority: 1st choice |
Medication:
|
Remarks:
SWAB remarks Niet behandelen. |
Sources
-
Pubmed.gov publication # 16380293
Stark DJ, Beebe N, Marriott D, Ellis JT, Harkness J (2006) Dientamoebiasis: clinical importance and recent advances. Trends Parasitol. 22(2):92-6.
-
http://ac.els-cdn.com/S2211320712000127/1-s2.0-S2211320712000127-main.pdf?_tid=8042ed40-7172-11e3-81db-00000aab0f02&acdnat=1388422414_e0df1ce2f55d9d6edc83f968eabbaff4
van Hellemond JJ, Molhoek N, Koelewijn R, Wismans PJ, van Genderen PJJ (2012) Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults? Int. J. Parasitol.: Drugs Drug Res. 2, 162-165
-
http://www.mimg.ucla.edu/faculty/campbell/drugs_for_parasites.pdf
CDC, Medical Letter 2004, Treatment of parasitic infections
-
Pubmed.gov publication # 4270059
Oakley GP 1973. The neurotoxicity of the halogenated hydroxyquinolines. A commentary. JAMA 225:395-7.
- SWAB Guideline IX - Acute infectieuze diarree
Menu position
Metadata
Swab vid: G-272393.3
Updated: 09/03/2019 - 12:41
Status: Published
General comments
Pathogeniciteit van deze darmprotozoa is zeer omstreden, behandeling is dus in principe niet geindiceerd.
BEHANDELING